Phase I study of epigenetic priming using azacitidine prior to neoadjuvant chemotherapy in patients with resectable esophageal and gastric adenocarcinoma.
Bryan J. Schneider
Research Funding - Celgene
Manish A. Shah
Honoraria - Celgene
Allyson J. Ocean
Honoraria - Roche/Genentech
Elizabeta C. Popa
No relevant relationships to disclose
Andrew Schreiner
No relevant relationships to disclose
Paul J. Christos
No relevant relationships to disclose
Alice Mercado
No relevant relationships to disclose
Romae Palmer
No relevant relationships to disclose
Jeffrey L. Port
No relevant relationships to disclose
Nasser K. Altorki
No relevant relationships to disclose
Joseph M Scandura
Research Funding - Celgene